Real-time biomedical studies possible through one of the world's largest ocular research centres

Article

Real-time biomedical studies of factors leading to vision impairment are now possible through one of the world's largest ocular research centre at Lions Eye Institute for Transplant & Research.

Real-time biomedical studies of factors leading to vision impairment are now possible through one of the world's largest ocular research centre at Lions Eye Institute for Transplant & Research. As the first research centre in the world to be directly combined with an eye bank, the Ocular Research Centre provides a repository of healthy and diseased ocular tissue for researchers from academic institutions, government organizations and the pharmaceutical industry.

For the first time, researchers can study the complete picture of health through tissue, medical history and family information, which will improve the understanding of underlying health factors leading to vision impairment and blindness. These studies will drive the development of new diagnostic tests and pharmacologic treatments for delaying, stopping and preventing progression of ocular diseases and conditions.

Over the past 30 years, Lions Eye Institute for Transplant & Research has provided 50,000 eyes for research and given the gift of sight through cornea transplantation to more than 30,000 men, women and children worldwide.“The Ocular Research Centre recently established a relationship with Emory University and we look forward to forming relationships with other organizations to accelerate drug innovation, provide timely clinical trials and formalize best practices,” said Jason Woody, Lions Eye Institute for Transplant & Research CEO.

Recent Videos
Durga Borkar, MD, MMCi, discusses FAS inhibition with ONL-1204
Theodore Leng, MD, MS, speaks about 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema:The FARETINA-DME Study
Rishi P. Singh, MD, discussed his presentation on the results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA
Carl C. Awh, MD, FASRS, speaks with Hattie Hayes of Ophthalmology Times Europe
Carl J. Danzig, MD
Martin Zinkernagel, MD, PhD, speaks about the ASRS sustainability expert panel
Srinivas Sai Kondapalli, MD, discusses outer retinal tubulations in lesion growth for subfoveal and non-subfoveal GA
Jennifer I. Lim, MD, FARVO, FASRS
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
© 2024 MJH Life Sciences

All rights reserved.